Form 8-K Keros Therapeutics, Inc For: Aug 04 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Rating) insider Jennifer Lachey sold 7,950 shares of the firm’s stock in a transaction dated Monday, April 4th. The shares were sold at an average price of $60.00, for a total value of $477,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through […]
Shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $63.27, but opened at $66.75. Keros Therapeutics shares last traded at $66.95, with a volume of 22 shares changing hands. Several research firms recently issued reports on KROS. HC Wainwright restated a […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Rating) – Research analysts at Jefferies Financial Group issued their Q2 2022 earnings per share (EPS) estimates for shares of Keros Therapeutics in a research report issued to clients and investors on Thursday, March 10th. Jefferies Financial Group analyst E. Yang anticipates that the company will post earnings per […]
Keros Therapeutics (NASDAQ:KROS – Get Rating)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Thursday, TipRanks reports. They currently have a $100.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 89.00% from the company’s previous close. […]